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ABSTRACT The CRISPR/Cas system has significant potential to facilitate gene edit-
ing in a variety of bacterial species. CRISPR interference (CRISPRi) and CRISPR activa-
tion (CRISPRa) represent modifications of the CRISPR/Cas9 system utilizing a catalyti-
cally inactive Cas9 protein for transcription repression and activation, respectively.
While CRISPRi and CRISPRa have tremendous potential to systematically investigate
gene function in bacteria, few programs are specifically tailored to identify guides in
draft bacterial genomes genomewide. Furthermore, few programs offer open-source
code with flexible design parameters for bacterial targeting. To address these limita-
tions, we created GuideFinder, a customizable, user-friendly program that can design
guides for any annotated bacterial genome. GuideFinder designs guides from NGG
protospacer-adjacent motif (PAM) sites for any number of genes by the use of an
annotated genome and FASTA file input by the user. Guides are filtered according
to user-defined design parameters and removed if they contain any off-target
matches. Iteration with lowered parameter thresholds allows the program to design
guides for genes that did not produce guides with the more stringent parameters,
one of several features unique to GuideFinder. GuideFinder can also identify paired
guides for targeting multiplicity, whose validity we tested experimentally. Guide
Finder has been tested on a variety of diverse bacterial genomes, finding guides for
95% of genes on average. Moreover, guides designed by the program are function-
ally useful—focusing on CRISPRi as a potential application—as demonstrated by es-
sential gene knockdown in two staphylococcal species. Through the large-scale gen-
eration of guides, this open-access software will improve accessibility to CRISPR/Cas
studies of a variety of bacterial species.
IMPORTANCE With the explosion in our understanding of human and environmen-
tal microbial diversity, corresponding efforts to understand gene function in these
organisms are strongly needed. CRISPR/Cas9 technology has revolutionized interro-
gation of gene function in a wide variety of model organisms. Efficient CRISPR guide
design is required for systematic gene targeting. However, existing tools are not
adapted for the broad needs of microbial targeting, which include extraordinary spe-
cies and subspecies genetic diversity, the overwhelming majority of which is charac-
terized by draft genomes. In addition, flexibility in guide design parameters is impor-
tant to consider the wide range of factors that can affect guide efficacy, many of
which can be species and strain specific. We designed GuideFinder, a customizable,
user-friendly program that addresses the limitations of existing software and that
can design guides for any annotated bacterial genome with numerous features that
facilitate guide design in a wide variety of microorganisms.
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The CRISPR/Cas system represents a considerable development in gene editingtechnology for a wide variety of organisms. Sequence-specific targeting is possible
through interactions between a complementary guide RNA and the target sequence
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and between the protospacer-adjacent motif (PAM) and the Cas nuclease. At the target
sequence, the Cas nuclease induces a double-stranded break which is subsequently
repaired by the cell by the use of nonhomologous end-joining (NHEJ), if present. This
often results in deleterious insertion or deletion mutations that can disrupt the function
of the target gene.
Given the broad activity and efficacy of Cas9, the CRISPR/Cas system has been used to
successfully edit genes across a diverse range of species (1–3), but its application to
bacterial genome editing has been more limited. For instance, many bacterial species do
not possess the machinery to efficiently repair double-stranded breaks, and targeting with
CRISPR/Cas is consequently lethal to the cell. Additionally, homologous recombination
(HR)-mediated repair requires introduction of a second template either as linear DNA or on
a supplemental plasmid. Nevertheless, the CRISPR/Cas9 system has significant potential to
facilitate gene-editing in a wide range of microorganisms (4). Moreover, additional tools
that do not depend on HR or NHEJ for disrupting gene function have since been devel-
oped, including CRISPR interference (CRISPRi) and CRISPR activation (CRISPRa).
CRISPRi and CRISPRa are modifications of the CRISPR/Cas system that employ a
catalytically inactive Cas9 protein (dCas9) for targeting (5). In the case of CRISPRi, dCas9
is used for transcriptional repression resulting from sterical blocking of transcription
machinery and preventing initiation or elongation, depending on the location of the
target sequence (on the promoter or DNA strand). CRISPRi has been recently applied on
a genomewide scale to identify essential genes and phage host factors in Escherichia
coli (6, 7). Given the ease of CRISPRi, this technology has the power to investigate gene
function in a variety of genetically diverse, nonmodel microorganisms on a genome-
wide scale; thus, flexible programs for high-throughput guide design in draft bacterial
are critically needed. CRISPRa works similarly, except it is fused to the omega subunit
of RNA polymerase, allowing increased recruitment of the polymerase when targeted
to sequences upstream of the 35 box of the promoter (5). While, to our knowledge,
CRISPRa has not been systematically applied genomewide in bacteria, it represents an
interesting potential application of this emerging technology.
For all systems, the efficiency of targeting and the occurrence of off-target effects
elsewhere in the genome are influenced by guide selection. A distance of a guide from
a transcription start site (TSS) (8), the GC content (9), the homopolymer content (10),
cross-reactivity to similar sequences in the genome, and sequence-specific toxicity (11)
have all been shown to affect targeting efficacy. While these guide design constraints
are important for efficient targeting, consideration of these multiple factors during
guide selection makes manual guide design impractical in large scale. This is of
particular importance in, for example, genomewide CRISPRi and CRISPRa studies, which
require the design of thousands of guides (12). Note also that additional factors such
as transcript/protein half-life and secondary structures that are difficult or impossible to
predict a priori from genome sequence can also affect targeting, increasing the
difficulty of systematic prediction of guides.
Existing tools for guide design are limited in their generalizability to large numbers of
diverse microbial genomes, which can differ greatly in GC content, length, and number of
repeat regions. Indeed, the majority of single guide RNA (sgRNA) design tools have been
developed exclusively for eukaryotes or for a few model organisms (11, 13–16). Other
programs possess flexibility with respect to the input genome but are limited by their
lower-throughput design (17), absence of user-defined filtering parameters and inability to
design paired guides (18), or inability to automatically perform iterations with relaxed
design parameters (17, 18). We have created GuideFinder to address these limitations,
providing a single, user-friendly R script that is a useful advance over existing algorithms.
RESULTS AND DISCUSSION
Creation and implementation of GuideFinder are described in Materials and Meth-
ods and outlined in Fig. 1. Here, we discuss GuideFinder’s key features in the context
of existing programs for guide design.
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Draft genome guide design. Some highly utilized software programs, such as
CHOP-CHOP (19), CCTop (14), and CRISPRdirect (20), are suitable only for available
complete genomes or perform only off-target searching of reference genomes. How-
ever, some species exhibit tremendous within-species variation. One example is that of
Staphylococcus epidermidis, whose gene content can differ up to 20% between strains
(21, 22). In such cases, the utility of a reference genome for guide design is limited.
Additionally, as the number of sequenced strains for a given species increases with
decreasing sequencing costs, the importance of tools for guide discovery that can
utilize these draft genomes increases. GuideFinder is designed for use with NCBI
reference complete or draft genomes (which can be called directly using the genome
accession number) or with user-inputted draft genomes.
User-defined filtering parameters. While most well-utilized programs have op-
tions for some user-defined filtering parameters, no program provides the level of
flexibility that GuideFinder affords in combination with the ability to use bacterial draft
genomes. Specifically, CCTop allows users to filter by guide length and off-target
prediction (14); CHOP-CHOP allows users to filter by guide length, GC content, off-
target prediction, self-complementarity, and guide efficiency score (as predicted in
mammalian cell lines) (19); and sgRNAcas9 allows users to filter by guide length,
off-target prediction, and distance between paired guides (18). Some of these programs
elegantly incorporate knowledge about guide efficiency prediction in mammalian cell
lines (19). But since none of these programs were developed specifically for targeting
in bacterial cells, they lack the functionality to use nonreference genomes (14, 19) or to
filter on the basis of guide sequence features that may affect guide efficiency in
bacterial cells, such as homopolymer runs of As and Ts and the “bad seed” effect in
which the presence of a short, specific nucleotide sequence contained in a targeting
guide results in a strong fitness defect (14, 17, 19). GuideFinder allows users to adjust
the following filtering parameters either initially or iteratively (allowing the user to relax
guide design parameters to increase the number of predicted targets): (i) distance from
the transcription start site; (ii) guide length; (iii) GC content; (iv) off-target predictions;
(v) sequence features such as homopolymer runs of As/Ts, the “bad seed effect”
(sequence toxicity), and restriction enzyme sequence; and (vi) distance between guides,
for paired-guide searches (i.e., simultaneous multiguide targeting of a single gene in
the same cell).
Multilocus targeting. We hypothesized that the efficiency of CRISPRi and CRISPRa
can be augmented by targeting multiple loci simultaneously and designed GuideFinder
FIG 1 GuideFinder workflow. Users set parameters and input FASTA files. Coding sequence and
promoter coordinates are identified and used to obtain sequences. PAM sites are identified, and guides
are created and filtered. Off-target searching is conducted using BLAST. The final guide selection step
creates a top hits list and a paired guides list. Genes without guides are identified and re-run with relaxed
parameters. CDS, coding DNA sequence; PAM, protospacer-adjacent motif; TSS, transcription start site; nt,
nucleotide.
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for flexibility for multiguide design. GuideFinder has the ability to design guides that
can be used to target different instances of the same gene simultaneously, taking into
account the size of the Cas footprint to help prevent steric hindrance of two or more
CRISPR/Cas complexes (23), with 100-bp default spacing between guides.
Iterative guide design. For genomewide or large-scale guide design, users may
want to design guides with stringent filtering parameters on first pass and then, if no
guides are identified for a particular gene, relax the parameters to enable recovery of
additional guides. GuideFinder automatically identifies genes lacking guides and iter-
atively searches these genes with relaxed parameters. This unique feature allows users
to identify additional guides without compromising the stringency for genes that
produce several guides.
User-friendly design and open-source code. We acknowledge that CRISPR/Cas
targeting in bacterial genomes is an emerging technology. As such, it is likely that new
biological findings will refine filtering parameters and guide design rules as the field
grows. For example, the importance of the “bad seed” effect was identified in E. coli
only recently (11). Thus, it is imperative that GuideFinder can be easily modified to grow
with the field as new knowledge about guide design rules for CRISPR/Cas targeting of
bacterial genomes emerges. For this reason, GuideFinder is provided as a well-
commented Rmarkdown script designed for users with little R programming experi-
ence and can also be readily edited to adapt to emerging rules in guide design or for
use with alternative PAM sites.
Scramble guide design. GuideFinder has the optional ability to design scramble
guides—i.e., guides with no match to the input genome—that can act as controls for
CRISPRi/a studies. To our knowledge, this is a feature unique to GuideFinder. The ability
to generate scramble guides is an important, albeit simple function in GuideFinder that
helps to improve access to high-throughput CRISPR studies in bacterial species.
Overall, the GuideFinder program is unique in that it combines all of the following
conditions in one program. (i) Reference or draft genomes can be utilized, and
off-target searches are performed against the actual genome in use and not a reference
genome. (ii) Guides are filtered according to user-defined parameters that are sug-
gested to affect Cas targeting in bacterial genomes. (iii) Guides can be designed for
multiguide targeting of a gene. (iv) If too few guides are identified, guide design
parameters can be relaxed; iteration through the software produces additional guides.
(v) Optionally, scramble/nontargeting guides, which are useful as nontargeting con-
trols, can be identified for the input genome. (vi) GuideFinder has been annotated in
detail and was designed for users with little to no programming experience. In addition,
the open-source code allows advanced users to make modifications to the program to
suit the needs of an emerging field.
In silico and in vitro testing of GuideFinder. GuideFinder is intended to reduce the
effort required to design guides targeting genes in any bacterial species, to accommo-
date both complete and draft genome annotations, and to provide to users the
flexibility to adjust the design parameters that may be vital with respect to the
organism of interest. GuideFinder was not designed to identify (in general) “better” or
more-efficient guides—the identity of such guides is likely highly dependent on the
bacterial species or strain of interest, and ideal design parameters suitable for all
bacterial species are unlikely to be determined. Rather, GuideFinder is intended to
provide to users a flexible program that can design guides using user-defined species
or strain-specific parameters (e.g., setting a low guide GC minimum while working with
a GC-poor species, filtering guides that contain a known “bad seed” for the organism
of interest, or retaining A/T homopolymer runs upon iteration in genes with few guide
options) and to be readily adaptable to include new features as the field develops.
Although users can elect to design guides for just one gene or just a few genes, if
desired, the program is intended to be particularly useful for large-scale guide design.
Next, focusing on GuideFinder’s applications for CRISPRi, to investigate these intended
uses, we conducted tests in silico and in vitro to determine (i) the utility of the program
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across diverse bacterial species and (ii) the ability of the program to design functional
guides. We demonstrate its utility in selecting guides genomewide for a diverse set of
bacterial species and its ability to select functional guides suitable for gene knockdown.
Guides for diverse genomes. (i) Testing on complete genomes. GuideFinder was
used to create guides across the genome for a diverse set of 10 complete bacterial
genomes (Table 1). These genomes were selected for their diversity in genome size,
percentage of gene duplications, and GC content. For each genome, preliminary
parameters were set as a GC minimum of 35%, a maximum distance from the TSS of
30%, and a minimum distance between guides of 100 bp, based on the projected
footprint of the Cas9 protein (23). These parameters have been utilized previously in
our laboratory for successful gene knockdown performed with CRISPRi and thus
represent rational design constraints. For each genome, genes that did not produce
suitable guide pairs or single guides were identified by the program. These genes were
re-run with the following constraints: a GC minimum of 30%, a maximum distance from
the TSS of 50%, retention of guides with homopolymers, and relaxed off-target search-
ing. These parameters were relaxed individually and in combination. The GuideFinder
program was able to successfully select guides for each of the diverse genomes
irrespective of genome size or GC content, but differences in outputs and run time were
observed (Fig. 2).
TABLE 1 Complete genomes testeda
Phylum Organism Genome size (Mb) % GC content
Firmicutes Lactobacillus brevis 2.29 45
Lactobacillus jensenii 1.67 34
Staphylococcus aureus 2.82 33
Staphylococcus epidermidis 2.49 32
Proteobacteria Acinetobacter baumannii 4.33 39
Rhizobium leguminosarum 4.85 60
Pseudomonas aeruginosa 6.26 66
Actinobacteria Mycobacterium tuberculosis 4.41 66
Micrococcus luteus 2.5 73
Streptomyces scabiei 10.41 71
aTen complete genomes, obtained from NCBI, were selected for their various genome sizes and levels of GC
content.
FIG 2 Performing testing on complete and draft genomes in silico. (A) Complete genomes. GuideFinder was tested on 10 complete genomes under conditions
of primary design constraints with iteration under conditions of relaxed constraints (individually and in combination). (B) Paired versus single guides. The
percentages of genes targeted by single guides versus paired guides were compared. (C) Complete genomes versus draft genomes. GuideFinder was tested
on 3 draft genomes; the percentage of genes with guides was compared to a complete genome of the same species.
GuideFinder for Microbial CRISPR/Cas9 Targeting
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GC content. As expected, the genomes with lower (40%) GC content were less
successful in producing usable guides for each gene. For the S. epidermidis, S. aureus,
Acinetobacter baumannii, and Lactobacillus jensenii genomes (GC content of 33%, 32%,
39%, and 34%, respectively), the percentages of genes producing guides by the use of
the primary filtering thresholds were considerably lower than the average for all 10
genomes (87.5%) at 68%, 67%, 79%, and 79%, respectively. The average for the
genomes with 40% GC content was 97.5%. However, for the genomes with low GC
content, iteration with lowered parameters was very useful in recovering genes that did
not originally produce guides. With each design constraint relaxed in combinations of
constraints, the percentages of genes with guides improved to 98%, 93%, 89%, and
96% for S. epidermidis, S. aureus, A. baumannii, and L. jensenii, respectively (Fig. 2A).
Gene duplications. We hypothesized that a genome known to contain a high
percentage of gene duplications, such as Mycobacterium tuberculosis, would have
difficulty producing a large number of usable guides, owing to the high probability of
off-target matching. Surprisingly, however, this genome was able to create guides for
98% of the genes using primary thresholds, probably owing to its relatively high GC
content (65%).
Genome size. Although GuideFinder was run successfully on each of the 10
genomes tested, run times increased with genome size due to the increased number
of genes and the subsequently increased number of potential guides (each of which is
analyzed for GC content, location, etc.). For example, the program takes approximately
10 min to complete using the S. epidermidis genome (2.49 Mb) but takes approximately
18 h for the largest genome tested, that of Sarcoptes scabiei (10.41 Mb). The genome of
S. scabiei is one of the largest known bacterial genomes; thus, we do not expect that
this issue will affect most users, but it represents a potential area of improvement for
future versions of GuideFinder.
(ii) Testing on draft genomes. Three draft genomes were selected to test utility for
incomplete genome annotations and were compared to a complete genome annota-
tion of the same species. Draft annotations were obtained from the Pathosystems
Resource Integration Center (PATRIC) (24), and whole-genome nucleotide sequences
and coding sequences for incomplete genomes were obtained from NCBI. Incomplete
genomes were preprocessed with the supplied script to identify gene coordinates.
Incomplete genome annotations were successfully used to design guides across the
genome for each of the three species tested. In terms of percentages of genes with
identified guides and run time, there are no appreciable differences between complete
and incomplete genome annotations (Fig. 2B). This result highlights the utility of the
program for both types of genome annotation files.
Essential gene knockdown to validate guides.We evaluated the functional utility
of GuideFinder guides by random assessment of essential gene knockdown in S. aureus
and S. epidermidis, focusing on CRISPRi as a potential application. With the exceptions
of groEl and rpoC, all of the guides showed effective knockdown, which manifested as
growth defects (Fig. 3). Further investigation measuring transcription of the locus using
quantitative PCR (qPCR) showed that the guide targeting rpoC did not reduce the level
of transcription (highlighting the value of predicting and testing multiple guides). groEL
was effectively targeted, but either the gene was nonessential under our tested
conditions or residual transcript might have been rescuing cell function (Fig. 4). Thus,
our GuideFinder parameters have been used for successful gene knockdown and
therefore represent rational design constraints. Overall, these results highlight the
utility of the GuideFinder program to create functional guides—demonstrated by
functional testing of essential genes—and underscore the need for continued investi-
gation of guide design for improved targeting efficacy in bacterial species. With
customizable, user-defined design parameters and access to program source code,
users are able to adjust guide selection as this information becomes available.
Multiguide design. GuideFinder is also capable of designing guides for multiguide
targeting, which may improve the efficacy of knockdown. Aside from the fact that
Spoto et al.
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overlapping guides have been shown to reduce knockdown efficiency, very little is
known about the impact of the distance between dual targeting guides on gene
knockdown in bacteria (6). However, it is plausible that the footprint of the Cas9 protein
may influence the ability of two nearby guides to target simultaneously. For this reason
and to allow flexibility as new information becomes available, GuideFinder allows users
to set a minimum distance threshold that guides selected for dual knockdown must
FIG 3 Essential gene knockdown. Essential genes were targeted for knockdown in S. aureus (A) and S.
epidermidis (B), and growth curves were created from OD measurements over the course of a 16-h
growth assay. ATc, anhydrotetracycline induction; Uninduced, control. The designation “Empty” (no
guide) acts as a control, indicating that the growth defect is not due to ATc administration. With the
exception of groEL and rpoC, the knockdown of most essential genes caused a growth defect, as
expected.
FIG 4 Relative expression levels of rpoC and groEL. mRNA levels of rpoC and groEL were measured in
knockdown strains over a 1.5-h growth assay. Transcript levels were normalized to the control strain at
each time point.
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meet. As expected, paired-guide creation—including a 100-bp distance-between-
guides threshold—is feasible for fewer genes than single guide creation, owing to the
fact that some genes may produce only a single suitable guide or may produce guides
that are located in close proximity to each other (Fig. 2C).
Nonetheless, we note that the molecular dynamics of using multiple guides for
multiplex targeting within the same gene is more complex than simply accounting for
steric hindrance. We tested the hypothesis that the targeting of multiple guides to the
same essential gene within one cell would lead to a level of growth defect that is equal
to or greater that occurring with a single targeting guide. For three essential S. aureus
genes—ftsZ, obg, and rplB—the three guides closest to the TSS were chosen for
single-guide and triple-guide knockdown (i.e., for simultaneous targeting). For each
gene, the use of the third single guide—that furthest from the TSS—did not result in
a growth defect, indicating that it was a nonfunctional guide or that the result
represented rescue of gene function due to partial knockdown. For all genes, use of the
first two single guides resulted in a growth defect. In the case of obg and rplB, the
triple-targeting construct—in which all three guides were expressed in the same
cell—resulted in growth defects similar to those seen with each of the single guides.
However, for ftsZ, the triple-targeting construct behaved similarly to the nonfunctional
third guide, resulting in the absence of a growth defect (Fig. 5A). Overall, the results of
the triple-guide targeting experiments were promising but were strongly suggestive of
guide-specific and gene-specific effects, representing an area to be further investigated.
FIG 5 Gene knockdown with multiplex guides. (A) Essential genes were targeted for knockdown in S.
aureus using single and triplet guides. Growth curves were created from absorbance measurements over
a 16-h growth assay. Triple guide knockdowns contain each of the three single guides targeting as a
group. (B) Double tandem guides can simultaneously repress two genes in E. coli. None, one, or two
guides were tested, each targeting a chromosomal ampicillin resistance gene and/or a plasmid-borne
GFP gene. Drug susceptibilities of the host are indicated. “” indicates robust colony growth or GFP
signal; “-” indicates that no colonies and no GFP signals were observed. Orange shading indicates critical
data. WT, wild type.
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On the other hand, targeting separate genes simultaneously could be very effective
in double knockdowns. We observed efficient repression of two distinct genes when we
tested dual-knockdown efficacy against chromosomal (ampicillin [Amp] resistance) and
plasmid (green fluorescent protein [GFP]) targets (Fig. 5B). While the widespread utility
of targeting of a single gene with multiple guides will be further investigated, we
demonstrated its feasibility and value in double knockdowns. Targeting two different
genes simultaneously has significant value for identifying gene-gene interactions,
particularly under large-scale conditions, given the facility of CRISPRi.
Conclusions. As the first user-friendly, pan-bacterial automated program suitable
for large-scale guide selection, this guide finder program is capable of designing guides
for any number of genes for any annotated bacterial genome. GuideFinder provides
users with a ready-to-use list of designed guides without the need for gene-by-gene
score comparison or additional filtering. In this way, the utility of GuideFinder lies in its
ability not only to design guides in a large-scale format, including guide multiplexing,
but also to provide users with the most suitable guide(s) for each input gene, according
to the parameters that they defined. By enabling high-quality, large-scale guide selec-
tion for any bacterial genome, GuideFinder improves access to high-throughput studies
of bacterial gene function, including genomewide CRISPRi and CRISPRa studies.
MATERIALS AND METHODS
GuideFinder implementation. GuideFinder is written in the R programming language and is
available free to use. GuideFinder was written such that it can be used to find guides for both complete
and draft genomes, with the recognition that many users may not have a complete genome for the
organism of interest. The workflow of the program, including inputs and outputs, is outlined in Fig. 1.
Inputs and outputs. (i) Inputs. GuideFinder is capable of designing guides for both complete and
draft genomes, although the inputs differ slightly.
Complete genome. For complete genomes, users simply supply the GenBank accession number and
FASTA file.
Draft genome. Given the variable organization and notation of draft genomes, annotated draft
genome files must be preprocessed prior to inputting into the program. Utilizing the supplied prepro-
cessing script, multisequence FASTA files (e.g., FASTA files containing sequence information for multiple
contigs) must be concatenated into a single sequence, with the addition of a series of N’s between
contigs. The coordinates of the coding sequences are then identified by aligning the coding sequences
against the concatenated FASTA file using BLAST and adjusted to the format required by the main
GuideFinder script (i.e., the smaller coordinate, designated the “start” coordinate). These coordinates are
then inputted into the main script, along with the single-sequence FASTA file.
(ii) Outputs. There are two main outputs of the GuideFinder program: top hits and paired guides
lists. Intermediate outputs, such as a list of all possible unfiltered guides, are also made available to the
user for reference.
Top hits list. The top hits list is a list of guides preferentially selected based on their proximity to the
transcription start site. The maximum number of guides supplied per gene is set by the user.
Paired guides list. The paired guides list is a list of guide pairs designed to doubly target the same
gene in the same cell to increase targeting efficiency. Suitable guide pairs are selected on the basis of
the distance between the guides, a parameter set by the user.
Program Workflow. (i) Coordinate identification. The identification of gene start and end coor-
dinates is the first step in the GuideFinder workflow, and the methods differ slightly for complete versus
draft genomes. For complete genomes, the script reads in the annotated genome file containing the
gene coordinates and modifies the coordinates to include the putative promoter region. For draft
genomes, the coordinates—identified during preprocessing—are directly inputted into the program and
modified to include the putative promoter region.
(ii) Coding and promoter sequence retrieval. The gene start and end coordinates are used to
retrieve the coding and putative promoter sequences from the FASTA file.
(iii) Guide creation. Searching within the promoter and gene body, the program identifies NGG PAM
sites and utilizes the sequences around each site to create three guides (of lengths 20 bp, 21 bp, and
22 bp) per PAM site. The selection of various guide lengths increases the number of potential guides,
many of which are lost to filtering, as described below.
(iv) Guide filtering. Guides are filtered according to default and user-defined parameters. By default,
the program removes any guides that contain a homopolymer run of A’s or T’s and guides of inadequate
length (20 bp). A user-set threshold is used for filtering based on the maximum distance from the start
site, as the targets closest to the transcriptional start site are the ones most likely to disrupt gene
function. Guides can be optionally filtered user-set “bad seed” or restriction enzyme sequences and used
to minimize off-target effects. For off-target filtering, the first 12 nucleotides (nt) closest to and including
the PAM site for each guide are aligned to the FASTA file, and guides that correspond to two or more
locations in the genome are discarded. While the sequence consisting of the first 12 nt of the PAM
sequence—the seed sequence—represents an established parameter for importance in off-target
GuideFinder for Microbial CRISPR/Cas9 Targeting
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searching (25), off-target prediction should be experimentally validated for each bacterial species tested
prior to large-scale guide design, as differences between species likely exist.
(v) Final guide selection. For each PAM site, the program selects the guide of the greatest length
that meets the GC minimum set by the user. From these guides, two final guide lists are created, i.e., top
hits and paired guides lists, which provide guides and guide pairs suitable for single-gene and dual-gene
knockdown, respectively.
(vi) Iteration. The program identifies genes that did not produce any guides with the primary
parameters. Users have the option to lower these thresholds and re-run these genes through the
program to identify additional guides. Users can elect to reduce the GC minimum, increase the maximum
guide distance from the transcription start site, retain guides that contain homopolymers, and relax
off-target searching. Users can relax each of these guide design constrains individually or in combination.
Knockdown strain creation. For both species, knockdown strains were created as follows. For
single-guide experiments, a single guide was designed by the GuideFinder program for targeting each
gene. For triple-guide targeting (i.e., using three guides expressed in the same cell), the top three guides
closest to the TSS were chosen for targeting each gene. The single-guide or triple-guide construct was
ligated into our custom CRISPR/dCas9 shuttle vector. Our CRISPR/dCas9 shuttle vector includes all of the
necessary components for CRISPRi, including dCas9 (derived from pDB114dCas9 [26]) under the control
of an anhydrotetracycline (ATc)-inducible promoter (derived from pRAB11 [27]), dCas9 handle (CRISPR
RNA [crRNA] and trans-activating small RNA [tracrRNA] fusion, custom designed), and a chloramphenicol
(Cm) resistance maker (for selection). The triple-guide targeting vector is a modified version of our
CRISPR/dCas9 single vector that enables insertions of multiple guides.
The shuttle vectors containing the proper targeting guides were transformed into E. coli, and the
resultant colonies were screened for the guide sequence. A single positive-testing colony was grown in
Trypticase soy broth (TSB) with chloramphenicol (TSM/Cm) overnight, and, using a QIAprep Spin
Miniprep kit, plasmids were isolated from E. coli and transformed into the staphylococcal species of
interest. For S. aureus, plasmids were transformed into competent S. aureus RN4220 cells via electropo-
ration. For S. epidermidis, phagemid transfer was utilized to incorporate the plasmid into S. epidermidis
strain Tu3298, according to a protocol previously described elsewhere (28).
For multigene targeting, using host strain E. coli HME63, a gift from Donald Court of the NIH which
possess an ampicillin (Amp) resistance gene (CRISPRi target 1), we performed transformations with a
plasmid bearing a kanamycin resistance gene (Kan) and a constitutive GFP gene (CRISPRi target 2). We
then cloned either single guides targeting each gene individually or double guides targeting both genes
simultaneously into our modified dCas9 vector. Six independent transformations were performed, the
results were plated onto the appropriate selective agar plates, and CFU counts were performed for
the Amp guide group. Single colonies from the GFP guide group were grown, and the fluorescence of
the cultures was measured with a Cytation 3 imaging reader (BioTek).
Growth assays. Growth assays were performed to assess knockdown of essential genes. The growth
assays were performed in both S. aureus and S. epidermidis as follows. A single colony of each knockdown
strain was grown overnight in TSB containing chloramphenicol. The overnight culture was diluted to an
optical density (OD) of 0.05 in TSB/Cm, grown to an OD of 0.5, and diluted again at the start of the assay
to an OD of 0.05 with TSB/Cm (control group) or TSB/Cm–0.1 M anhydrotetracycline (inducer,
experimental group). The cultures were grown for 16 h, with OD measurements taken each half-hour to
construct a growth curve for each knockdown strain. For each strain, the induced/experimental group
growth curve was compared to the uninduced/control group curve. Knockdown of most of the essential
genes resulted in a severe growth defect, as expected. The knockdown of two genes, groEL and rpoc, did
not result in the expected growth defect, and we investigated the ability of each guide to reduce
transcript levels.
Measuring transcript levels. In S. aureus, we measured transcript levels of groEL and rpoc growing
in liquid media to determine if the selected guide was capable of reducing transcript levels. A single
colony of each groEL and rpoc knockdown S. aureus strain was grown overnight in TSB/Cm at 37°C with
shaking. The overnight culture was back-diluted to an OD of 0.05 and was grown at 37°C until an optical
density at 600 nm (OD600) of 0.5 was reached. The culture was back-diluted again to an OD of 0.05 with
TSB containing chloramphenicol and 0.1 M anhydrotetracycline and was grown for 1.5 h; readings were
taken at time points throughput the assay (h 0, 0.5, 1, and 1.5). An aliquot taken at each time point was
mixed with 2 volumes of RNA Protect and incubated for 5 min at room temperature. The aliquot was
spun down, and the supernatant was decanted and stored at 20°C until RNA extraction. RNA from the
four time points was extracted according to the protocol for an RNeasy Plus kit, with an added enzymatic
digestion step performed using lysozyme and lysostaphin for lysis of the Gram-positive species S. aureus.
RNA was reversed transcribed to create cDNA by the use of a High-Capacity cDNA reverse transcription
kit (Applied Biosystems), according to provided instructions. Quantitative PCR (qPCR) was performed
using PowerUp SYBR green master mix (Applied Biosystems) in conjunction with gene-specific primers.
Primers amplifying the ftsZ gene were used as an internal control, and nontemplate controls were
included. Duplicate qPCR reactions were performed for each assay as a technical replicate.
The genomes used for draft genome analysis were obtained from PATRIC. The strain used and
the genome identifier (ID) numbers are as follows: Micrococcus luteus ATCC 12698 (Genome ID
1270.61), Micrococcus luteus O’Kane (Genome ID 1270.50), Staphylococcus aureus WBG10049 (Ge-
nome ID 585160.3), Staphylococcus aureus SA14-296 (Genome ID 46170.233), Staphylococcus epider-
midis NLAE-zl-G239 (Genome ID 1282.2004), and Staphylococcus epidermidis FDAARGOS_83 (Genome
ID 1282.1163).
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Availability of and requirements for GuideFinder. Details of the availability of and requirements
for GuideFinder are as follows: project name, GuideFinder; project home page, https://github.com/ohlab/
Guide-Finder; operating system(s), Mac, Windows; programming language, R. Other requirements are as
follows: license, none; restrictions for use by nonacademics, none.
Data availability. The genomes used for complete genome analysis were obtained from NCBI. The
accession numbers for each strain are as follows: for Lactobacillus brevis, GenBank accession no.
CP000416.1; for Lactobacillus jensenii, GenBank accession no. CP018809.1; for Staphylococcus epidermidis,
GenBank accession no. AE015929.1; for Staphylococcus aureus, GenBank accession no. CP000253.1; for
Rhizobium leguminosarum, GenBank accession no. CP007045.1; for Pseudomonas aeruginosa, GenBank
accession no. AE004091.2; for Mycobacterium tuberculosis, GenBank accession no. AL123456.3; for
Micrococcus luteus, GenBank accession no. CP001628.1; for Streptomyces scabiei, GenBank accession no.
FN554889.1.
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